Zhengye Biotechnology Holdings/$ZYBT
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Zhengye Biotechnology Holdings
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry, and other vaccines.
Ticker
$ZYBT
Sector
Primary listing
Employees
277
Headquarters
Website
ZYBT Metrics
BasicAdvanced
$92M
-
-$0.06
-
-
Price and volume
Market cap
$92M
52-week high
$14.30
52-week low
$1.40
Average daily volume
26K
Financial strength
Current ratio
1.494
Quick ratio
1.005
Long term debt to equity
1.287
Total debt to equity
23.491
Interest coverage (TTM)
-7.31%
Profitability
EBITDA (TTM)
-0.314
Gross margin (TTM)
37.37%
Net profit margin (TTM)
-12.60%
Operating margin (TTM)
-17.79%
Effective tax rate (TTM)
23.42%
Revenue per employee (TTM)
$79,450
Management effectiveness
Return on assets (TTM)
-3.45%
Return on equity (TTM)
-6.38%
Valuation
Price to revenue (TTM)
4.113
Price to book
0.31
Price to tangible book (TTM)
0.34
Price to free cash flow (TTM)
-2,900.85
Free cash flow yield (TTM)
-0.03%
Free cash flow per share (TTM)
-0.001
Growth
Revenue change (TTM)
-18.98%
Earnings per share change (TTM)
-193.78%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Zhengye Biotechnology Holdings stock?
Zhengye Biotechnology Holdings (ZYBT) has a market cap of $92M as of December 16, 2025.
What is the P/E ratio for Zhengye Biotechnology Holdings stock?
The price to earnings (P/E) ratio for Zhengye Biotechnology Holdings (ZYBT) stock is 0 as of December 16, 2025.
Does Zhengye Biotechnology Holdings stock pay dividends?
No, Zhengye Biotechnology Holdings (ZYBT) stock does not pay dividends to its shareholders as of December 16, 2025.
When is the next Zhengye Biotechnology Holdings dividend payment date?
Zhengye Biotechnology Holdings (ZYBT) stock does not pay dividends to its shareholders.
What is the beta indicator for Zhengye Biotechnology Holdings?
Zhengye Biotechnology Holdings (ZYBT) does not currently have a Beta indicator.